5F-JWH-398
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C24H21ClFNO |
Molar mass | 393.89 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
5F-JWH-398 (4'-chloro-AM-2201, Cl-2201, CLAM, SGT-20) is a recreational designer drug which is classed as a synthetic cannabinoid. It is from the naphthoylindole family, and produces cannabis-like effects. It was legally sold in New Zealand from 2012-2014 under the psychoactive substances scheme but was discontinued in May 2014 following the end of the interim approval period under the Psychoactive Substances Act 2013.[1][2][3] Subsequently it has appeared on the illicit market around the world and was identified in Germany in May 2019.[4]
See also
References
- ↑ Davison I (27 April 2014). "Government to ban all legal highs within two weeks". Retrieved 30 November 2017 – via www.nzherald.co.nz.
- ↑ Rychert M, Wilkins C (November 2016). "Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand". The International Journal on Drug Policy. 37: 90–97. doi:10.1016/j.drugpo.2016.08.011. PMID 27639994.
- ↑ Rychert M, Wilkins C, Witten K (September 2017). "Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand". Drug and Alcohol Review. 36 (5): 589–596. doi:10.1111/dar.12507. PMID 28229493. S2CID 20279160.
- ↑ European Monitoring Center for Drugs and Drug Addiction (December 2020). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System (PDF). Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 978-92-9497-558-4.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.